Abstract
Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have